COMPARATIVE ANTIBACTERIAL ACTIVITY OF CEF PODOXIME AGAINST HAEMOPHILUS-INFLUENZAE, STREPTOCOCCUS-PYOGENES, STREPTOCOCCUS-PNEUMONIAE, AND MORAXELLA-CATARRHALIS
C. Wallrauchschwarz et al., COMPARATIVE ANTIBACTERIAL ACTIVITY OF CEF PODOXIME AGAINST HAEMOPHILUS-INFLUENZAE, STREPTOCOCCUS-PYOGENES, STREPTOCOCCUS-PNEUMONIAE, AND MORAXELLA-CATARRHALIS, Arzneimittel-Forschung, 44-1(5), 1994, pp. 668-670
The antimicrobial activity of cefpodoxime (Podomexef(R), CAS 80210-62-
4) against 236 clinical isolates of H. influenzae, Moraxella catarrhal
is, Streptococcus pyogenes and Streptococcus pneumoniae was investigat
ed and compared with that of another 8 commonly used oral antibiotics.
beta-Lactamase negative, beta-lactamase positive and multiresistant s
trains of H. influenzae were inhibited by cefpodoxime at a concentrati
on of 0.13 mg/l. 10% of Moraxella catarrhalis isolates were moderately
susceptible to cefpodoxime, with minimum inhibitory concentration (MI
C) of cefpodoxime ranging between 0.13 and 2.0 mg/l. All isolates of S
treptococcus pyogenes and Streptococcus pneumoniae were susceptible to
less than or equal to 0.25 mg/l cefpodoxime. Cefpodoxime was clearly
more active than the older oral cephalosporins against all species tes
ted. The activity was comparable to that of cefixime against all speci
es except Streptococcus pneumoniae, against which cefpodoxime was more
active than cefixime.